Sun Pharmaceutical Industries Limited
SUNPHARMA
Rank in Stocks
#525
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Share Price
$19.19
Market Cap
$46.04B
Change (1 day)
-0.25%
Change (1 year)
-0.09%
Country
IN
Trade Sun Pharmaceutical Industries Limited (SUNPHARMA)
Category
Healthcare
Stock price history for Sun Pharmaceutical Industries Limited (SUNPHARMA)
Highest end of day price: $19.47 on 2026-10-01
Lowest end of day price: $0.02 on 1996-01-01
Lowest end of day price: $0.02 on 1996-01-01
Stock price history of Sun Pharmaceutical Industries Limited from 1996 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 0.87% |
| 2025 | -7.91% |
| 2024 | 43.53% |
| 2023 | 22.20% |
| 2022 | 18.11% |
| 2021 | 33.19% |
| 2020 | 27.66% |
| 2019 | 1.58% |
| 2018 | -27.66% |
| 2017 | -14.52% |
| 2016 | -16.96% |
| 2015 | -11.56% |
| 2014 | 40.91% |
| 2013 | 40.72% |
| 2012 | 36.94% |
| 2011 | -4.41% |
| 2010 | 58.19% |
| 2009 | 46.03% |
| 2008 | -24.72% |
| 2007 | 32.88% |
| 2006 | 46.09% |
| 2005 | 25.97% |
| 2004 | 74.23% |
| 2003 | 127.83% |
| 2002 | 1.28% |
| 2001 | 3.29% |
| 2000 | -13.97% |
| 1999 | 1,277.91% |
| 1998 | 21.14% |
| 1997 | 7.46% |
| 1996 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $7.09 | -23.44% |
CN
|
